Prevention of glucocorticoid-induced osteoporosis with alendronate or alfacalcidol: Relation between change in bone mineral density, bone markers and calcium homeostasis.

被引：0
|
作者：
Jacobs, JWG
de Nijs, RNJ
Lems, WF
Geusens, PP
Huisman, MAM
Laan, RFJ
Bijlsma, JWJ
机构：
[1] Univ Utrecht, Med Ctr, Utrecht, Netherlands
[2] Free Univ Amsterdam Hosp, Amsterdam, Netherlands
[3] State Univ Limburg Hosp, NL-6201 BX Maastricht, Netherlands
[4] Sint Franciscus Hosp, Rotterdam, Netherlands
[5] Univ Med Ctr, Nijmegen, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S295 / S295
页数：1
相关论文
共 50 条
  • [1] Prevention of glucocorticoid induced osteoporosis with alendronate or alfacalcidol: Relations of change in bone mineral density, bone markers, and calcium homeostasis
    Jacobs, Johannes W. G.
    de Nijs, Ron N. J.
    Lems, Willem F.
    Geusens, Piet P. M. M.
    Laan, Roland F. J.
    Huisman, Anne-Margriet
    Algra, Ale
    Buskens, Erik
    Hofbauer, Lorenz C.
    Oostveen, Ans C. M.
    Bruyn, George A. W.
    Dijkmans, Ben A. C.
    Bijlsma, Johannes W. J.
    JOURNAL OF RHEUMATOLOGY, 2007, 34 (05) : 1051 - 1057
  • [2] Alendronate versus alfacalcidol in the prevention of glucocorticoid-induced bone loss
    Hahn, Bevra H.
    Hahn, Theodore J.
    NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2007, 3 (01): : 10 - 11
  • [3] Alendronate versus alfacalcidol in the prevention of glucocorticoid-induced bone loss
    Bevra H Hahn
    Theodore J Hahn
    Nature Clinical Practice Rheumatology, 2007, 3 : 10 - 11
  • [4] Prevention of Glucocorticoid-induced Osteoporosis with Alendronate or Alfacalcidol in Patients with Ophthalmologic Diseases
    Ikeda, T.
    Hamanishi, C.
    Souen, S.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S218 - S218
  • [5] Correlations between biochemical markers of bone turnover and bone density responses in patients with glucocorticoid-induced osteoporosis treated with teriparatide or alendronate
    Burshell, Alan L.
    Moericke, Ruediger
    Correa-Rotter, Ricardo
    Chen, Peiqi
    Warner, Margaret R.
    Dalsky, Gail P.
    Taylor, Kathleen A.
    Krege, John H.
    BONE, 2010, 46 (04) : 935 - 939
  • [6] Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs
    Akahoshi, S
    Sakai, A
    Arita, S
    Ikeda, S
    Morishita, Y
    Tsutsumi, H
    Ito, M
    Shiraishi, A
    Nakamura, T
    JOURNAL OF BONE AND MINERAL METABOLISM, 2005, 23 (05) : 341 - 350
  • [7] Modulation of bone turnover by alfacalcidol and/or alendronate does not prevent glucocorticoid-induced osteoporosis in growing minipigs
    Shojiro Akahoshi
    Akinori Sakai
    Shinobu Arita
    Satoshi Ikeda
    Yoshiomi Morishita
    Hideki Tsutsumi
    Masako Ito
    Ayako Shiraishi
    Toshitaka Nakamura
    Journal of Bone and Mineral Metabolism, 2005, 23 : 341 - 350
  • [8] Baseline Glucocorticoid Dose and Bone Mineral Density Response with Teriparatide or Alendronate Therapy in Patients with Glucocorticoid-induced Osteoporosis
    Devogelaer, Jean-Pierre
    Adler, Robert A.
    Recknor, Chris
    See, Kyoungah
    Warner, Margaret R.
    Wong, Mayme
    Krohn, Kelly
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (01) : 141 - 148
  • [9] Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density
    Hayashi, K.
    Yamamoto, M.
    Murakawa, Y.
    Yamauchi, M.
    Kaji, H.
    Yamaguchi, T.
    Sugimoto, T.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 (11) : 1889 - 1894
  • [10] Bone fragility in male glucocorticoid-induced osteoporosis is not defined by bone mineral density
    K. Hayashi
    M. Yamamoto
    Y. Murakawa
    M. Yamauchi
    H. Kaji
    T. Yamaguchi
    T. Sugimoto
    Osteoporosis International, 2009, 20 : 1889 - 1894
12345